Dina Mehaney

Prof. Dina Mehaney


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2020 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
RDRania K. Darwish
Rania K. Darwish
AHAlireza Haghighi
Alireza Haghighi
ZSZeinab S. Seliem
Zeinab S. Seliem
SESonia A. El-Saiedi
Sonia A. El-Saiedi
NRNora H. Radwan
Nora H. Radwan
DMDina Mehaney
Dina Mehaney
Paediatric cardiomyopathy is a progressive and often lethal disorder and the most common cause of heart failure in children. Despite their severe outcomes, their genetic etiology is still poorly characterised. The current study aimed at uncovering the genetic background of idiopathic primary hypertrophic cardiomyopathy in a cohort of Egyptian children using targeted next-generation sequencing. The study included 24 patients (15 males and 9 females) presented to the cardiomyopathy clinic of Cairo University Children’s Hospital with a median age of 2.75 (0.5–14) years. Consanguinity was positive in 62.5% of patients. A family history of hypertrophic cardiomyopathy was present in 20.8% of patients. Ten rare variants were detected in eight patients; two pathogenic variants (8.3%) in MBPC3 and MYH7, and eight variants of uncertain significance in MYBPC3, TTN, VCL, MYL2, CSRP3, and RBM20.Here, we report on the first national study in Egypt that analysed sarcomeric and non-sarcomeric variants in a cohort of idiopathic paediatric hypertrophic cardiomyopathy patients using next-generation sequencing. The current pilot study suggests that paediatric hypertrophic cardiomyopathy in Egypt might have a particular genetic background, especially with the high burden of consanguinity. Including the genetic testing in the routine diagnostic service is important for a better understanding of the pathophysiology of the disease, proper patient management, and at-risk detection. Genome-wide tests (whole exome/genome sequencing) might be better than the targeted sequencing approach to test primary hypertrophic cardiomyopathy patients in addition to its ability for the identification of novel genetic causes.

26 May 2021 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
DMDina Mehaney
Dina Mehaney
AHAlireza Haghighi
Alireza Haghighi
AEAmira K. Embaby
Amira K. Embaby
RZReham A. Zeyada
Reham A. Zeyada
RDRania K. Darwish
Rania K. Darwish
ZSZeinab S. Seliem
Zeinab S. Seliem
Background: Paediatric cardiomyopathy is a progressive, often lethal disorder and the most common cause of heart failure in children. Despite its severe outcomes, the genetic aetiology is still poorly characterised. High-throughput sequencing offers a great opportunity for a better understanding of the genetic causes of cardiomyopathy.Aim: The current study aimed to elucidate the genetic background of cardiomyopathy in Egyptian children.Methods: This hospital-based study involved 68 patients; 58 idiopathic primary dilated cardiomyopathy and 10 left ventricular noncompaction cardiomyopathy. Cardiomyopathy-associated genes were investigated using targeted next-generation sequencing.Results: Consanguinity was positive in 53 and 70% of dilated cardiomyopathy and left ventricular noncompaction cardiomyopathy patients, respectively. Positive family history of cardiomyopathy was present in 28% of dilated cardiomyopathy and 10% of the left ventricular noncompaction cardiomyopathy patients. In 25 patients, 29 rare variants were detected; 2 likely pathogenic variants inTNNI3andTTNand 27 variants of uncertain significance explaining 2.9% of patients.Conclusions: The low genetic detection rate suggests that novel genes or variants might underlie paediatric cardiomyopathy in Egypt, especially with the high burden of consanguinity. Being the first national and regional report, our study could be a reference for future genetic testing in Egyptian cardiomyopathy children. Genome-wide tests (whole exome/genome sequencing) might be more suitable than the targeted sequencing to investigate the primary cardiomyopathy patients. Molecular characterisation of cardiomyopathies in different ethnicities will allow for global comparative studies that could result in understanding the pathophysiology and heterogeneity of cardiomyopathies.

1 June 2013 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
NBNoussa El Basha
Noussa El Basha
MMMona Mohsen
Mona Mohsen
MKMarwa Kamal
Marwa Kamal
DMDina Mehaney
Dina Mehaney

29 April 2022 in African Health Sciences
Verified
Journal Article
Open access
PDF file
ZSZeinab Salah Seliem
Zeinab Salah Seliem
DMDina Mehaney
Dina Mehaney
LSLaila Abd Elmoteleb Selim
Laila Abd Elmoteleb Selim
SESonia Ali El-Saiedi
Sonia Ali El-Saiedi
RIReem Ibrahim Ismail
Reem Ibrahim Ismail
Mohamed A. ElmonemMohamed A. Elmonem
Mohamed A. Elmonem
Background: Inborn errors of metabolism (IEMs) commonly present with pediatric cardiomyopathy. Identification of the underlying cause is necessary as it may lead to improved outcomes. Objectives: We aimed to investigate the diagnostic rate, the clinical, and biochemical spectra of IEMs among Egyptian pediatric patients presenting with cardiomyopathy, and their outcome measures. Methods: We retrospectively analyzed the clinical, biochemical, and radiological data of 1512 children diagnosed with cardiomyopathy at Cairo University Children’s Hospital over a 5-year duration. Results: Two hundred twenty-nine children were clinically suspected as IEMs and underwent metabolic workup. Nineteen different IEMs were confirmed in 57 (24.4%) of the suspected children. Their median age at presentation was 2.6 years and the majority had extra-cardiac manifestations. Hypertrophic cardiomyopathy represented 43/57 (75.4%) of confirmed cases, while dilated cardiomyopathy represented 13/57 (22.8%), and one patient presented with a mixed phenotype. Twenty- six patients (45.6%) survived, while 31 patients (54%) either died or were lost to follow up and assumed deceased. Conclusions: We developed for the first time a database and a diagnostic scheme for metabolic cardiomyopathies in Egyptian children. With the recent introduction of enzyme replacement therapy, many metabolic disorders became treatable, thus establishing an early and accurate diagnosis is extremely important. Keywords: Cardiomyopathy; inborn errors of metabolism; pediatric.

1 January 2023 in Pediatrics International
Verified
Journal Article
Closed access
DMDina Mehaney
Dina Mehaney
ZSZeinab S. Seliem
Zeinab S. Seliem
LSLaila A. Selim
Laila A. Selim
MKMona S. Khalil
Mona S. Khalil
HAHazem S. Abou‐Youssef
Hazem S. Abou‐Youssef
SESherihan H. Elkady
Sherihan H. Elkady

7 June 2022 in Gene Reports
Verified
Journal Article
Closed access
RDRania K. Darwish
Rania K. Darwish
WRWalaa A. Rabie
Walaa A. Rabie
DADina M. El Abd
Dina M. El Abd
LSLaila A. Selim
Laila A. Selim
ZSZeinab S. Seliem
Zeinab S. Seliem
DMDina Mehaney
Dina Mehaney